<aside>
Background Parenchymal Enhancement (BPE) refers to the normal physiologic enhancement of fibroglandular breast tissue following intravenous gadolinium contrast administration on dynamic contrast-enhanced MRI (DCE-MRI).
</aside>
It represents the degree of contrast uptake by normal (non-lesional) breast parenchyma, reflecting its vascularity and permeability.
After contrast injection, normal glandular tissue shows some degree of enhancement due to:
This enhancement is non-focal, diffuse, symmetric or asymmetric, and varies between individuals and within the menstrual cycle.
BPE is not a lesion—it is a background physiologic phenomenon that can, however, influence the detection and interpretation of breast pathology on MRI.
| Parameter | Represents |
|---|---|
| Fibroglandular Tissue (FGT) | Volume of glandular tissue within the breast (morphologic feature, seen on non-contrast images) |
| Background Parenchymal Enhancement (BPE) | Degree of contrast enhancement of that glandular tissue (functional/physiologic feature, seen post-contrast) |
Thus, two women with similar FGT can have different BPE depending on hormonal status and vascularity.
Estrogen and progesterone receptors in breast stroma and epithelium regulate angiogenesis and vascular permeability.
Under hormonal stimulation (luteal phase, premenopause, or HRT use):
Capillary permeability ↑
Interstitial edema and perfusion ↑
→ More intense contrast enhancement of normal tissue.
Postmenopausal women (without hormone therapy) have low vascularity, hence minimal BPE.